Show simple item record

dc.contributor.authorRashuamán-Conche, Benny Harold
dc.contributor.authorGamboa-Cárdenas, Rocio Violeta
dc.contributor.authorPimentel-Quiroz, Victor Román
dc.contributor.authorSingh, Anubhav
dc.contributor.authorReátegui-Sokolova, Cristina
dc.contributor.authorElera-Fitzcarrald, Claudia
dc.contributor.authorGarcia-Hirsh, Samira
dc.contributor.authorPastor-Asurza, Cesar
dc.contributor.authorRodríguez-Bellido, Zoila
dc.contributor.authorPerich-Campos, Risto Alfredo
dc.contributor.authorAlarcón, Graciela S.
dc.contributor.authorUgarte-Gil, Manuel Francisco
dc.date.accessioned2026-10-02T18:03:38Z
dc.date.available2026-10-02T18:03:38Z
dc.date.issued2026-06-12
dc.identifier.citationLupus Science & Medicine. 2026;13.es_PE
dc.identifier.urihttps://hdl.handle.net/20.500.12959/6077
dc.description.abstractObjective Frailty has been shown to predict damage accrual in patients with systemic lupus erythematosus (SLE), including those from Latin America. However, the impact of frailty on mortality has been scarcely evaluated, particularly in Latin American populations. The aim of this study was to evaluate frailty as a predictor of mortality in Latin American SLE patients. Methods Patients from a single-centre 2012–2025 prevalent cohort were studied. Mortality was defined as the vital status according to the Peruvian Department of Health. Frailty was ascertained using the Systemic Lupus International Collaborating Clinics Frailty Index (SLICC-FI) as a continuous variable. Univariable and multivariable Cox regression models were done to estimate its impact on mortality. Multivariable models were adjusted for possible confounders. Sensitivity analyses were performed including data up to March 2020 to avoid the potential influence of the COVID-19 pandemic. Additionally, a Kaplan-Meier curve was calculated by frail status (frail, SLICC-FI >0.21; non-frail, SLICC-FI ≤0.21). Results Four hundred and ninety-five patients were included, 456 (92.1%) were women and 96 (19.4%) were frail. Their mean (SD) age at diagnosis was 35.0 (14.0) years, their mean disease duration at baseline was 6.7 (6.1) years and their mean follow-up time was 8.5 (4.2) years. Fifty-six (11.3%) patients died during the follow-up. The SLICC-FI predicted mortality even after adjusting for possible confounders (hazard ratio (HR)=1.54 (CI 95% 1.11 to 2.14), p=0.010). This prediction capability remained on the sensitivity analyses (HR 1.85; (95% CI 1.30 to 2.61), p<0.001). Conclusion Frailty, as ascertained with the SLICC-FI, was a predictor of mortality in a Latin American cohort of SLE patients. Frailty could be considered in the monitoring of SLE patients; possible interventions to modify it should be developed.es_PE
dc.formatapplication/pdfes_PE
dc.language.isoenges_PE
dc.publisherLupus Foundation of Americaes_PE
dc.relation.urihttps://lupus.bmj.com/content/13/1/e001938es_PE
dc.rightsinfo:eu-repo/semantics/openAccesses_PE
dc.rights.urihttps://creativecommons.org/licenses/by-nc-sa/4.0/es_PE
dc.subjectEnfermedades autoinmuneses_PE
dc.subjectLupus eritematoso sistémicoes_PE
dc.subjectMortalidades_PE
dc.subjectPerúes_PE
dc.titleSystemic lupus international collaborating clinics frailty index predicts mortality in systemic lupus erythematosus patients: data from the Almenara Lupus Cohortes_PE
dc.typeinfo:eu-repo/semantics/articlees_PE
dc.subject.ocdehttps://purl.org/pe-repo/ocde/ford#3.02.15es_PE
dc.identifier.doihttps://doi.org/10.1136/lupus-2025-001938


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record

info:eu-repo/semantics/openAccess
Except where otherwise noted, this item's license is described as info:eu-repo/semantics/openAccess

El repositorio recopila la documentación y publicaciones institucionales, producto de la investigación y el desempeño en defensa de la competencia, la propiedad intelectual y protección al consumidor, para su difusión en el entorno social y académico. Se difunde en acceso abierto y está alineado con las Declaraciones de Budapest y de Berlín.

Contactos